Next Article in Journal
Comprehensive Survey of Consensus Docking for High-Throughput Virtual Screening
Previous Article in Journal
Migration Modeling as a Valuable Tool for Exposure Assessment and Risk Characterization of Polyethylene Terephthalate Oligomers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Schiff Base in Ketoamine Form and Rh(η4-cod)-Schiff Base Complex with Z′ = 2 Structure from Pairwise C-H···Metallochelate-π Contacts

1
Department of Chemistry, Jahangirnagar University, Dhaka 1342, Bangladesh
2
Institut für Anorganische Chemie und Strukturchemie, Universität Düsseldorf, Universitätsstr. 1, D-40225 Düsseldorf, Germany
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(1), 172; https://doi.org/10.3390/molecules28010172
Submission received: 22 November 2022 / Revised: 14 December 2022 / Accepted: 19 December 2022 / Published: 25 December 2022

Abstract

:
Condensation of 2-hydroxybenzaldehyde (salicylaldehyde) or 2-hydroxy-1-naphthaldehyde with 2-ethylaniline yields the Schiff base compound of (E)-2-(((2-ethylphenyl)imino)methyl)phenol (HL1) or (E)-1-(((2-ethylphenyl)imino)methyl)naphthalen-2-ol (HL2), which in turn react with the dinuclear complex of [Rh(η4-cod)(µ-O2CCH3)]2 (cod = cycloocta-1,5-diene) to afford the mononuclear (η4-cod){(E)-2-(((2-ethylphenyl)imino)methyl)phenolato-κ2N,O}rhodium(I), [Rh(η4-cod)(L1)] (1) or (η4-cod){(E)-1-(((2-ethylphenyl)imino)methyl)naphthalen-2-olato-κ2N,O}rhodium(I), [Rh(η4-cod)(L2)] (2) (L1 or L2 = deprotonated Schiff base ligand). The X-ray structure determination revealed that the HL2 exists in the solid state not as the usual (imine)N···H-O(phenol) form (enolamine form) but as the zwitterionic (imine)N-H+···O(phenol) form (ketoamine form). 1H NMR spectra for HL2 in different solvents demonstrated the existence of keto-enol tautomerism (i.e., keto ⇆ enol equilibrium) in solution. The structure for 1 and 2 showed that the deprotonated Schiff base ligand coordinates to the Rh(η4-cod)-fragment as a six-membered N^O-chelate around the rhodium atom with a close-to-square-planar geometry. Two symmetry-independent molecules (with Rh1 and Rh2) were found in the asymmetric unit in 1 in a structure with Z’ = 2. The supramolecular packing in HL2 was organized by π-π and C-H···π contacts, while only two recognized C-H···π contacts were revealed in 1 and 2. Remarkably, there were reciprocal or pairwise C-H···π contacts between a pair of each of the symmetry-independent molecules in 1. This pairwise C-H contact to the Rh-N^O chelate (metalloaromatic) ring may be a reason for the two symmetry-independent molecules in 1. Differential scanning calorimetry (DSC) analyses revealed an irreversible phase transformation from the crystalline-solid to the isotropic-liquid phase and subsequently confirmed the thermal stability of the compounds. Absorption spectra in solution were explained by excited state properties from DFT/TD-DFT calculations.

Graphical Abstract

1. Introduction

The bidentate N,O-chelate (HL) or tetradentate N2,O2-chelate (H2L′) Schiff base ligands react with the dinuclear [Rh(η4-cod)(µ-X)]2 (cod = 1,5-cyclooctadiene; X = Cl, OMe, O2CMe) to give the mononuclear [Rh(η4-cod)(L)] or dinuclear [{Rh(η4-cod)}2(L′)] complexes [1,2,3,4,5,6,7,8,9,10]. These types of Rh(η4-cod)-Schiff base complexes have been used with excellent conversion and chemoselectivity towards hydroformylation and polymerization reactions [5,6,7,8,9,10]. Similar reactions with the chiral bidentate N,N-chelate Schiff base ligands generated the analogous chiral Rh(η4-cod)-Schiff bases complexes, which were used for the enantioselective hydrogenation or hydrosilylation of ketone derivatives [11,12,13,14,15,16]. Most of these studies evaluated catalytic activities of Rh(η4-cod)-complexes, which are significantly influenced by the structures of the catalyst as well as the coordination geometry around the rhodium atom [7,10,11,12,13,14]. Although the first article on Rh(η4-cod)-Schiff base complexes was published by Cozens et al. in 1971 [1], there was no structural information available until the molecular structure of dinuclear [{Rh(η4-cod)}2(L′)] {H2L′ = H2salophen = N,N′-(1,2-phenylene)bis(salicylideneimine)} was reported by Bonnaire et al. in 1982 [4]. The salophen ligand acts as a bridge between two Rh(I) atoms with a nearly square-planar geometry, giving a twisted conformation.
Our studies on Rh(η4-cod)-complexes with chiral N,O-chelate Schiff base ligands, synthesized from dinuclear [Rh(η4-cod)(µ-O2CMe)]2, showed considerable interest in their syntheses, molecular structures and catalytic properties [17,18,19,20,21]. Indeed, we first reported structurally elucidated chiral mononuclear [Rh(η4-cod)(L)] (L = salicylaldiminato/naphthaldiminato) [17,18]. Similar reaction with achiral N,O-chelate Schiff bases (HL) or with the tetradentate N2,O2-chelate Schiff bases (H2L′ = H2salen or H2salophen) gave the mononuclear [Rh(η4-cod)(L)] [19,20] or dinuclear [{Rh(η4-cod)}2(L′)] [20]. The X-ray molecular structure determination showed a six-membered N,O-chelation of the salicylaldiminates (including salen or salophen) or naphthaldiminates to the Rh(η4-cod)-fragment with distorted square planar geometry at the rhodium atom. Some of these complexes were tested for reduction of acetophenone into (rac)-1-phenyl-ethanol in the presence of diphenylsilane with conversions up to ca. 95% [18,21].
Extended studies on Rh(η4-cod)-complexes using chiral-amino acids/-amino alcohols instead of Schiff bases showed the interesting features of coordination and supramolecular chemistry [20,22,23]. In this connection, we have reported the mononuclear neutral [Rh(η4-cod)(AA)] (AA = chiral/achiral-amino carboxylato) and the cationic [Rh(η4-cod)(AOH)](O2CMe) (AOH = chiral-amino alcohol) [20,21,22]. The X-ray molecular structures showed a five-membered N,O-chelation of amino-carboxylate or amino-alcohol to the Rh(η4-cod)-fragment in distorted square planar geometry at the rhodium atom. Structural analyses further explored the observation that the achiral N-phenylglycinate provided a racemate of Rh(η4-cod)(N-phenylglycinate), with the nitrogen atom becoming the stereogenic center upon metal coordination. A two-fold spontaneous resolution of the racemate and its supramolecular packing provided two homo-chiral supramolecular helix-enantiomers, namely a (left-handed) P43- and (right-handed) P41-helical chain [20,22].
The present paper, in continuation, reports the results of synthesis, spectroscopy and molecular structures of the N,O-chelate Schiff bases (HL1 or HL2) and their complexes of [Rh(η4-cod)(L1)] (1) or [Rh(η4-cod)(L2)] (2) (Scheme 1). The molecular structures for HL2, 1 and 2 were elucidated by single-crystal X-ray diffraction and are discussed along with the supramolecular packing analysis. 1H NMR studies revealed HL2 to exhibit keto-enol tautomerism in solution, while at solid-state, it remains as the zwitterionic (imine)N-H+···O(phenol) (ketoamine form). The optimized geometry and excited state properties were studied by DFT/TD-DFT and compared with the experimental results.

2. Results and Discussion

The reaction of 2-hydroxybenzaldehyde (salicylaldehyde) or 2-hydroxy-1-naphthaldehyde with 2-ethylaniline gives the Schiff bases of (E)-2-(((2-ethylphenyl)imino)methyl)phenol (HL1) or (E)-1-(((2-ethylphenyl)imino)methyl)naphthalen-2-ol (HL2) (Scheme 2). These Schiff bases react with dinuclear (η4-cycloocta-1,5-diene)(acetato)rhodium(I), [Rh(η4-cod)(µ-O2CCH3)]2 in a mixture of C6H6:MeOH (2:1, v/v) to provide the mononuclear complexes of (η4-cod){(E)-2-(((2-ethylphenyl)imino)methyl)phenolato-κ2N,O}rhodium(I), [Rh(η4-cod)(L1)] (1) and (η4-cod){(E)-1-(((2-ethylphenyl)imino)methyl)naphthalen-2-olato-κ2N,O}rhodium(I), [Rh(η4-cod)(L2)] (2) (L1 or L2 = deprotonated Schiff base ligand) (Scheme 2). IR spectra showed the main characteristic imine band (νC=N) at 1616/1595 cm−1 (HL1) and 1609/1597 cm−1 (HL2) for the Schiff bases, which shift to 1609/1586 cm−1 (1) and 1616/1603 cm−1 (2) upon coordination to the metal ion. Electron impact (EI) mass spectra (Figure S1, Supplementary Materials) contained the molecular ion peak at m/z = 435 (1) and 485 (2) followed by several ion peaks for the Schiff base ligands and their fragmented species (see experimental section).
1H NMR spectra of the Schiff base ligands (HL1 and HL2) and the complexes (1 and 2) in CDCl3 are shown in Figure 1 (Figure S2 and Table 1), and they corresponded well to those of related Schiff bases and their Rh(η4-cod)-complexes [17,18,19,20,21]. Methyl (CH3) and methylene (CH2) protons appeared as a triplet at 1.24–1.34 ppm (JHH = 7.6 Hz) and a quartet at 2.81–2.90 ppm (JHH = 7.6 Hz) in the Schiff bases, respectively. These peaks were found as a triplet at 1.33 (1)/1.35 (2) ppm (JHH = 7.6 Hz) and a quartet at 2.93 (1)/2.92 (2) ppm (JHH = 6.8 Hz) in the complexes. The imine proton (CH=N) showed a singlet at 8.62 (HL1) and 9.34 (HL2) ppm for the Schiff bases and at 8.77 (1) and 9.36 (2) ppm for the complexes. The Schiff bases showed a broad peak at most downfield at 13.47 (HL1) and 15.63 ppm (HL2) for the phenolic proton (OH), which disappeared upon coordination to the metal ion. The broad peak corresponded to an exchange of the phenolic proton between the oxygen (enol-form) and nitrogen (keto-form) atoms, which resulted in a dynamic keto ⇆ enol tautomerism (i.e., keto ⇆ enol equilibrium) in solution as discussed below [24]. The presence of a naphthyl-ring in HL2 or 2 shifted the imine proton signal downfield by ca. 0.70 ppm in contrast to that in HL1 or 1 due to an electron donating inductive effect. Similarly, the phenolic proton signal shifted downfield by ca. 2.10 ppm in HL2 in contrast to that in HL1. 1H NMR spectra for the complexes showed signals for the exo- and endo-methylene protons (CH2codexo and CH2codendo) of the rhodium-coordinated 1,5-cyclooctadiene as a multiplet at 1.77–1.79 and 2.52–2.54 ppm, respectively [17,18,19,20,21]. The four olefinic (CHcod) protons showed a single peak at 4.27 (1) and 4.26 (2) ppm, suggesting their symmetric nature in the coordination sphere [20,22,23,24]. In contrast, the analogous Rh(η4-cod)-salicylaldiminates/naphthaldiminates showed two or four peaks for four olefinic protons, indicating their asymmetric nature in the coordination sphere [17,18,19,20,21].

2.1. UV-Vis Spectra and Excited State Properties

Absorption spectra for the Schiff base (HL1) and complexes (1 and 2) in chloroform are shown in Figure 2. The spectra for the complexes were almost identical, while they were a bit different from that of the Schiff base. The Schiff base showed three very strong bands below 400 nm with absorption maxima (λmax) at 227 nm (εmax = 12,440 L mol−1 cm−1), 267 nm (εmax = 8000 L mol−1 cm−1) and 341 nm (εmax = 7030 L mol−1 cm−1) for different intra-ligand π→π/n→π transitions (LL) [17,18,19,20,21]. The complexes showed these intra-ligand transitions bands below 365 nm with absorption maxima at λmax = 323 nm (εmax = 8163 L mol−1 cm−1) and 275 nm (9413 L mol−1 cm−1) for 2, which were seen as a shoulder at ca. 310 nm for 1 due to shifting to the higher energy. The complexes further revealed a medium broad band at 365–500 nm with λmax = 399 nm (εmax = 2099 L mol−1 cm−1) for 1 and 417 nm (εmax = 2638 L mol−1 cm−1) for 2. This was due to metal–ligand charge transfer (ML) transitions based on the formation of [Rh(η4-cod)]+ and [Rh(L1 or L2)] species in [Rh(η4-cod)(L1 or L2)] (1 or 2), as reported for the analogous Rh(η4-cod)-Schiff bases/amino-acids complexes [17,18,19,20,21].
The excited state properties (simulated UV-Vis spectra) for compound 1 or 2, calculated by TD-DFT at B3LYP/SDD, and the experimental spectra are shown in Figure 3. Some selected excited state properties and simplified assignments associated with the experimental bands are listed in Table 2 and discussed herein. The results showed that the excitation occurred from the combination of several MM, ML and LL transitions at a particular wavelength (excited state) (Tables S2 and S3). Indeed, excitation energies related to these transitions are very close, overlap with each other and make them difficult to interpret independently and in a simple manner [19,23,25,26]. Hence, a combined band consisting of MM (d-d) and ML transitions appeared at 475 (1) or 487 (2) nm, with the highest molecular orbital (MO) contribution of 98% (1) or 97% (2) and an oscillator strength (f) of 0.0022 or 0.0030 for the HOMO to LUMO transitions, respectively, (Figure 3, inset), which were not seen in the experimental spectra. Similarly, a combined band comprising all three transitions (MM, ML and LL) was found at λmax = 402 (1) or 410 (2) nm, with the second highest MO contribution of 71% (1) or 76% (2) (f = 0.0426 or 0.0662) for the HOMO-1 to LUMO transitions, respectively, which were very close to the observed band at λmax = 399 (1) or 417 (2) nm in the experimental spectra. In fact, the simulated spectra further indicated several very strong bands at shorter wavelengths with significant MO contributions and oscillator strength in parallel with the experimental spectra (Figure 3 and Table 2).
Although the metal centred d–d (MM) electron transitions for the diamagnetic closed shell transition metals like Rh(I) and Zn(II) are not allowed, there were some d-electron clouds in the HOMO/HOMO–1. This is due to identical symmetry of the metal-d MO and ligand MOs, which provides a small amount of the electron clouds to the metal-d MO (Figure 4 and Figure S8). In fact, a very small amount of the electron clouds was observed in the LUMO, which reflected minor back donation again due to identical symmetry. As a result, excited state properties possibly deliver a very small d–d (MM) contribution in addition to the metal–ligand and/or ligand–ligand (ML/LL) π-transitions (Figure 4 and Figure S8 and Table 2) [19,23,25,26]. The frontier HOMO-1, HOMO and LUMO are presented in Figure 4 and Figure S8. The HOMO comprised mostly metal-dz2 electron moieties, while the HOMO-1 comprised metal-dz2, sal/naphthal-π and (η4-cod)-π electron moieties. The LUMO comprised sal/naphthal-σ and -π with a small number of metal-dxy electrons moieties. The energy gap for HOMO to LUMO transitions is considerably low (ΔE = 2.43 (1) or 2.26 (2) eV) and results in the highest MO contributions (e.g., 98 or 97%) to the excitation protocol.

2.2. X-ray Analyses

The X-ray molecular structure revealed that the ligand HL2 exists as the zwitterionic (imine)N-H+···O(phenol) (ketoamine form) in the solid-state (Figure 5a), which is occasionally seen in Schiff base compounds [27]. The N-H proton could be found and refined. The molecular packing in HL2 is organized by a π-π and a C-H···π contact (Figure S4). The molecular structures for the rhodium complex 1 or 2 demonstrated that the deprotonated Schiff base ligand (L1 or L2) coordinated to the Rh(η4-cod)-fragment as a six-membered N,O-chelate ligand to the rhodium atom with a close-to-square-planar geometry if one considers the midpoints of the cod double bonds and the N,O donor atoms (Figure 5b,c).
There are two symmetry-independent molecules in the asymmetric unit in compound 1. This included a molecule with Rh1 and a molecule with Rh2 (Figure 5b), as reported in the analogous Rh(η4-cod)-Schiff base complexes [17,19]. Two symmetry-independent molecules or two identical chemical formula units in the asymmetric unit [28] define a structure with Z′ = 2, where Z′ is the number of formula units in the unit cell (which is eight in 1) divided by the number of independent general positions (four in 1) [29]. Structures with Z′ > 1 [30] can signal a metastable structure [28,29,30,31,32,33], two co-existing conformations of very similar energy in a molecule [34,35,36] or originate from special supramolecular interactions among or between the symmetry-independent units [37,38,39,40,41,42].
The molecular packing in 1 and 2 was largely controlled by van der Waals interactions between the C-H groups. There were no π-π interactions and only two recognized C-H···π contacts each between the molecules in 1 and 2 (Figures S5 and S6). Remarkably, in 1, there were reciprocal or pairwise C-H···π contacts between a pair of each of the symmetry-independent molecules (Figure 6). Both C-H···π contacts originated from the ortho-C-H atom of the ethylphenyl ring and pointed onto the six-membered Rh-N^O chelate ring. This metallacycle can be regarded as metalloaromatic according to Masui, who had proposed an electron delocalization within a metal–heterocyclic chelate ring so that it exhibited metalloaromaticity [43,44,45,46,47,48]. This pairwise C-H contact to the Rh-N^O chelate ring could be a reason for the two symmetry-independent molecules in 1. In 2, the C-H···π contacts were a normal interaction between two naphthyl C-H atoms onto either the naphthyl or the ethylphenyl ring (Figure S6).
The coordination around Rh in the molecular structure of 1 or 2 was also seen in the closely related structures of Rh(η4-cod)-complexes with the chiral/achiral-Schiff base ligands [5,6,7,8,9,10,17,18,19,20]. Selected bond lengths and angles for HL2, 1 and 2 are listed in Table 3. They were comparable to the analogous Rh(η4-cod)-Schiff bases complexes [5,6,7,8,9,10,17,18,19,20]. The Rh−C (cod-ligand) bond lengths in 1 or 2 were slightly different, which reflected the fact that the Rh atom was bound asymmetrically to the C=C olefinic carbon atoms trans to the nitrogen or oxygen donor atoms. The structures for 1 and 2 were optimized at B3LYP/SDD (Figure S7) and provided similar results as the X-ray molecular structures (Table 3).

2.3. Keto-Enol Tautomerism

To check the existence of keto-enol tautomerism (i.e., keto ⇆ enol equilibrium) in the solution (Scheme 3) [24,48], we ran 1H NMR spectra for HL1 and HL2 in CD3OD and DMSO-d6 in addition to CDCl3 (Figure S3 and Table 1). A significant chemical shift downfield by ca. 0.12 ppm (CDCl3) and 0.30 ppm (DMSO-d6) for CH=N and ca. 0.44 ppm (DMSO-d6) for OH was observed with increasing solvent polarity from CDCl3 to CD3OD to DMSO-d6 for HL2. Similarly, the CH=N peak shifted downfield by 0.28 ppm (DMSO-d6) for HL1. The CH=N peak appeared in duplicate with a separation of 18.0 Hz in CD3OD, which corresponded to the presence of both the keto- and enol forms with an equilibrium of almost equimolar amounts in solution. However, the peak for OH (enol form) and/or NH (keto form) was not seen in CD3OD due to rapid proton-exchange with the alcoholic group (OD). In DMSO-d6, the spectrum also showed two peaks (separated by ca. 5.0 Hz) for CH=N or OH/NH. The exchange of the phenolic proton (OH) between the oxygen and nitrogen atoms is considerably slow on the 1H NMR time scale, which results in the detection of both signals for keto- and enol-forms in CD3OD and DMSO-d6, which stabilize the ionic ketoamine form.

2.4. Phase Transformation and Thermal Stability

The differential scanning calorimetry (DSC) curves for HL2, 1 and 2 are show in Figure 7 (Figure S10) and data are listed in Table 4. The heating curves showed an endothermic peak with a considerable amount of heat of transformation (ΔH/kJ mol−1), which corresponded to a phase transformation from the crystalline-solid to isotropic-liquid phase and subsequently confirmed the thermal stability of the compounds, as reported for the analogous Rh(η4-cod)-Schiff base complexes [19]. The cooling curves showed no peak on the reverse direction, suggesting an irreversible phase transformation. The repeated heating curves in the second cycle for the same probe reproduced similar peaks for HL2, while no peak was observed for 1 or 2. The phase transformation temperature for 2 (ca. 221 °C) was considerably higher than 1 (ca. 185 °C), which corresponds to higher thermal stability in accordance with the high molecular weight. Similarly, the free ligand (HL2) showed a low phase transformation temperature (ca. 92 °C) due to low molecular weight.

3. Materials and Methods

3.1. Materials and Characterization

All reactions were carried out under dry nitrogen gas using collecting flux. Solvents were dried and redistilled under nitrogen prior to use: benzene over Na metal and methanol over CaO. IR spectra were recorded on a Nicolet iS10 spectrometer as KBr discs at ambient temperature. UV-Vis spectra were measured with a Shimadzu UV 1800 spectrophotometer in chloroform at 25 °C. Differential scanning calorimeter (DSC) analyses were performed on a Shimadzu DSC-60 at the range of 30–240 °C (ca. 5 °C above the corresponding melting point) with a rate of 10 K min–1. 1H NMR spectra were recorded on a Bruker Avance DPX 400 spectrometer at 20 °C in CDCl3, DMSO-d6 or CD3OD. Electron impact (EI) mass spectra were recorded with a Thermo-Finnigan TSQ 700 mass spectrometer.

3.2. Synthesis of the Ligands

2-Hydroxybenzaldehyde (salicylaldehyde: 1.22 g, 10.0 mmol) or 2-hydroxy-1-naphthaldehyde (1.7218 g, 10.0 mmol) was dissolved into 20 mL of ethanol, and 3–4 drops of concentrated H2SO4 were added into the solution, which was then stirred for ca. 10 min at room temperature. An equimolar amount of 2-ethyl aniline (1.2118 g, 10.0 mmol, dissolved in 5 mL of ethanol) was slowly added to this solution. The reaction mixture was then refluxed for ca. 23 h for 2-hydroxybenzaldehyde and ca. 6 h for 2-hydroxy-1-naphthaldehyde. Thin-layer chromatography (TLC) was run to monitor the progress of the reaction. After completion of the reaction, the volume of the solution was reduced to about 70% by a rotary evaporator. This concentrated solution was left standing in open air for crystallization via slow evaporation of the solvent. A semi-liquid product was obtained after 3–4 days, which was then dried in open air to get brown-yellow (E)-2-(((2-ethylphenyl)imino)methyl)phenol (HL1). After one day, a precipitate was formed, filtered off and washed three times with ethanol followed by n-hexane (2 mL each). The products were dried in open air to obtain orange-yellow microcrystals of (E)-1-(((2-ethylphenyl)imino)methyl)naphthalen-2-ol (HL2). X-ray quality single crystals were grown by slow evaporation of a concentrated methanol solution of HL2 at room temperature.
(E)-2-(((2-ethylphenyl)imino)methyl)phenol (HL1) or (E)-1-(((2-ethylphenyl)imino)-methyl)naphthalen-2-ol (HL2): Yield: 1.75 g (78%, based on 2-hydroxybenzaldehyde). IR (KBr): ν = 3059, 3017, 2967, 2932 w (H-Ar), 1616, 1595 vs. (C=N) and 1570 vs. (C=C) cm–1. UV-Vis (0.10 mM, MeOH): λmax/nm (εmax/L mol−1 cm−1) = 341 (7030), 267 (8000) and 227 (12,440). 1H NMR (400 MHz, CDCl3): δ/ppm = 1.28 (t, JHH = 7.6 Hz, 3H, CH3), 2.84 (q, JHH = 7.6 Hz, 2H, CH2), 6.99 (t, JHH = 7.6 Hz, 1H, H4), 7.08 (d, JHH = 8.0 Hz, 1H, H2), 7.13 (dd, JHH = 6.4, 1.6 Hz, 1H, H12), 7.27–7.33 (m, 3H, H10,11,13), 7.40–7.46 (m, 2H, H3,5), 8.62 (s, 1H, CHN) and 13.47 (br, H, OH/NH) (for hydrogen atom numbering, see Scheme 1).
1H NMR (400 MHz, DMSO-d6): δ/ppm = 1.17 (t, JHH = 7.6 Hz, 3H, CH3), 2.73 (q, JHH = 7.6 Hz, 2H, CH2), 6.97–7.02 (m, 2H, H2,4), 7.25–7.28 (m, 1H, H12), 7.29–7.33 (m, 3H, H10,11,13), 7.44 (t, JHH = 7.00 Hz, 1H, H3), 7.68 (d, JHH = 7.6 Hz, 1H, H5), 8.90 (s, 1H, CHN) and 13.31 (br, 1H, OH/NH).
(E)-1-(((2-ethylphenyl)imino)methyl)naphthalen-2-ol (HL2): Yield: 2.20 g (80%, based on 2-hydroxy-1-naphthaldehyde). IR (KBr): ν = 3097, 3034, 2966, 2933 w (H-Ar), 1620, 1597 vs. (C=N) and 1543 vs. (C=C) cm–1. UV-Vis (0.10 mM, CHCl3): λmax/nm (εmax/L mol−1 cm−1) = 442 (6257), 376 (7343) and 318 (8771). 1H NMR (400 MHz, CDCl3): δ/ppm = 1.34 (t, JHH = 7.6 Hz, 3H, CH3), 2.90 (q, JHH = 7.6 Hz, 2H, CH2), 7.17 (d, JHH = 9.2 Hz, 1H, H14), 7.30 (d, JHH = 9.6 Hz, 1H, H17), 7.35–7.39 (m, 4H, H2,6,15,16), 7.55 (t, JHH = 8.0 Hz, 1H, H7), 7.74 (d, JHH = 8.0 Hz, 1H, H8), 7.84 (d, JHH = 9.2 Hz, 1H, H5), 8.13 (d, JHH = 8.4 Hz, 1H, H3), 9.34 (s, 1H, CHN) and 15.63 (br, 1H, OH/NH) (for hydrogen atom numbering, see Scheme 1).
1H NMR (400 MHz, CD3OD): δ/ppm = 1.33 (dt, JHH = 7.6, 4.0 Hz, 3H, CH3), 2.88 (dq, JHH = 7.6, 7.2 Hz, 2H, CH2), 6.94 (t, JHH = 8.8 Hz, 1H, H16), 7.24–7.41 (m, 4H, H2,14,15,17), 7.51–7.56 (m, 1H, H6), 7.64–7.72 (m, 2H, H7,8), 7.85 (t, JHH = 10 Hz, 1H, H5), 8.24–8.29 (m, 1H, H3) and 9.46, 9.51 (s, 1H, CHN) (for hydrogen atom numbering, see Scheme 1).
1H NMR (400 MHz, DMSO-d6) δ/ppm = 1.24 (t, JHH = 7.6 Hz, 3H, CH3), 2.81 (q, JHH = 7.6 Hz, 2H, CH2), 7.04 (d, JHH = 9.2 Hz, 1H, H14), 7.27 (t, JHH = 7.2 Hz, 1H, H16), 7.35–7.40 (m, 3H, H2,15,17), 7.55 (t, JHH = 7.6 Hz, 1H, H6), 7.80 (t, JHH = 7.6 Hz, 2H, H7,8), 7.95 (d, JHH = 9.2 Hz, 1H, H5), 8.51 (d, JHH = 8.4 Hz, 1H, H3), 9.65, 9.66 (s, 1H, CHN) and 16.06, 16.07 (s, 1H, OH/NH) (for hydrogen atom numbering, see Scheme 1).

3.3. Synthesis of the Complexes

Two equivalents of HL1 or HL2 (112.6 mg or 137.5 mg, 0.5 mmol) and one equivalent of [Rh(η4-cod)(O2CMe)]2 (134.2 mg, 0.25 mmol) were dissolved in 10 mL of a mixture of C6H6:MeOH (2:1, v/v) under N2 gas and were kept stirring at room temperature. The color changed immediately from orange-red to bright yellow, and a precipitate formed within 30 min in the reaction with HL2. The solution was stirred for another ca. 6 h at room temperature. The precipitate was collected through filtration, washed three times with methanol (1 mL each) and dried in vacuo at 40 °C to obtain bright yellow microcrystals of [Rh(η4-cod)(L2)] (2). In the reaction with HL1, no precipitate was formed after 6 h of stirring, and the solvent was then evaporated to dryness in a rotary evaporator in vacuo at 40 °C. The residue was dissolved in 2 mL of a mixture of C6H6:MeOH (2:1, v/v), stirred for ca. 30 min and again dried in a rotary evaporator in vacuo at 40 °C. This process was repeated three times, and finally, bright yellow microcrystals of [Rh(η4-cod)(L1)] (1) were obtained. Single crystals suitable for X-ray diffraction measurements were grown by slow diffusion of n-hexane into a concentrated dichloromethane solution of 1 or 2 after 3–4 days at room temperature.
[Rh(η4-cod)(L1)] (1): Yield: 0.150 g (70%), based on [Rh(η4-cod)(O2CMe)]2. IR (KBr): ν = 3057, 3017, 2951, 2934 w (H-Ar), 1609, 1586 vs. (C=N) and 1574, 1528 s (C=C) cm–1. UV-Vis (0.20 mM, CHCl3): λmax/nm (εmax/L mol−1 cm−1) = 399 (2099) and 285 sh. 1H NMR (400 MHz, CDCl3): δ/ppm = 1.33 (t, JHH = 7.6 Hz, 3H, CH3), 1.77–1.79 (m, 4H, CH2codexo), 2.52–2.54 (m, 4H, CH2codendo), 2.93 (q, JHH = 6.8 Hz, 2H, CH2), 4.27 (s, 4H, =CHcod), 7.05–7.07 (m, 1H, H-Ar), 7.21–7.27 (m, 1H, H-Ar), 7.38–7.49 (m, 4H, H-Ar), 7.61–7.65 (m, 2H, H-Ar) and 8.77 (s, 1H, CHN). MS (EI, 70 eV): m/z (%) = 435 (80) [M]+, 325 (100) [M–cod–H2]+, 295 (20) [M–cod–H2–(CH3CH3)]+, 208 (10) [C6H5CHNHRh]+, 192 (7) [HL1–NH2OH]+, 182 (10) [HL1–CH3CHO+H]+, 168 (15) [HL1–CH3CH2CHO+H]+, 103 (10) [Rh]+ and 77 (5) [C6H5]+.
[Rh(η4-cod)(L2)] (2): Yield: 0.180 g (74 %), based on [Rh(η4-cod)(O2CMe)]2. IR (KBr): ν = 3050, 3011, 2965, 2926 w (H-Ar), 1616, 1603 vs. (C=N) and 1572, 1533 s (C=C) cm–1. UV-Vis (0.08 mM, CHCl3): λmax/nm (εmax/L mol−1 cm−1) = 417 (2638), 325 (8300) and 275 (9413). 1H NMR (400 MHz, CDCl3): δ/ppm = 1.35 (t, JHH = 7.6 Hz, 3H, CH3), 1.77–1.79 (m, 4H, CH2codexo), 2.52–2.54 (m, 4H, CH2codendo), 2.92 (q, JHH = 6.8 Hz, 2H, CH2), 4.26 (s, 4H, =CHcod), 7.37–7.43 (m, 4H, H-Ar), 7.55–7.68 (m, 2H, H-Ar), 7.77 (d, JHH = 7.6 Hz, 1H, H-Ar), 7.93–7.99 (m, 2H, H-Ar), 8.14 (d, JHH = 7.2, Hz, 1H, H-Ar) and 9.36 (s, 1H, CHN). MS (EI, 70 eV): m/z (%) = 485 (80) [M]+, 375 (100) [M–cod–H2]+, 343 (15) [M–cod–H2–(CH3CH3)]+, 275 (15) [HL2]+, 242 (10) [HL2–NH2OH]+, 218 (40) [L2–CH3CH2CHO]+, 105 (10) [C6H5CH2CH3–H]+, 103 (7) [Rh]+ and 77 (10) [C6H5]+.

3.4. Computational Method

Computations were performed with the Gaussian 09 program package [49]. The initial geometries for optimization were generated from the X-ray structures of compounds 1 and 2, respectively. The initial geometry was optimized with B3LYP/3-21G, which was then reoptimized with B3LYP/SDD [19,23,50,51,52]. For calculations of excited state properties, time-dependent density functional theory (TD-DFT) was employed with different combinations of the functionals B3LYP and M06 and the basis sets SDD and DEF2SVP. The simulated spectra thus obtained were very similar with little shifting of band maxima and were also comparable with the experimental spectra (Figure S9). These results further suggest the validity and reliability of the methods employed. The PCM (Polarization Continuum Model) in chloroform and 72 excited states (roots) were considered for the calculations (Tables S2 and S3) [19,23]. Assessments of excited state properties and molecular orbitals (MOs) calculations were carried out at the same level of theory. The simulated spectra were generated with the software SpecDis (version 1.71) [53,54] applying the Gaussian band shape with an exponential half-width σ = 0.16 eV.

3.5. X-ray Structure Determination

Suitable crystals were carefully selected under a polarized light microscope covered in protective oil and mounted on a cryo-loop. The single crystal diffraction data was collected using a Rigaku XtaLAB Synergy S four circle diffractometer with a Hybrid Pixel Array Detector and a PhotonJet X-ray source for Cu-Kα radiation (λ = 1.54184 Å) with a multilayer mirror monochromator. Data collection at 100.0 ± 0.1 K using ω-scans. Data reduction and absorption correction were performed with CrysAlisPro 1.171.41.105a [55]. The structures were solved using direct methods (SHELXT-2015), and full-matrix least-squares refinements on F2 were carried out using the SHELXL-2017/1 program package in OLEX 2.1.3 [56,57,58]. All hydrogen atoms on C were positioned geometrically (with C–H = 0.95 Å for aromatic and aliphatic CH, C–H = 1.00 Å for ternary CH, C–H = 0.99 Å for CH2 and C–H = 0.98 Å for CH3) and were refined using riding models (AFIX 43, 13, 23 and 137 with Uiso(H) = 1.2 Ueq(CH, CH2) and 1.5 Ueq(CH3). The protic hydrogen atom for NH in HL2 was found and refined freely. Crystal data and details on the structure refinement are given in Table 5. Graphics were drawn with the program DIAMOND [59]. Computations on the supramolecular interactions were carried out with PLATON for Windows [60,61,62]. The CCDC numbers 2201154-2201156 for HL2, 1 and 2, respectively, contain the supplementary crystallographic data reported in this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

4. Conclusions

The mononuclear complexes of [Rh(η4-cod)(L1)] (1) and [Rh(η4-cod)(L2)] (2) were synthesized from the Schiff bases of (E)-2-(((2-ethylphenyl)imino)methyl)phenol (HL1) and (E)-1-(((2-ethylphenyl)imino)methyl)naphthalen-2-ol (HL2), respectively. The X-ray structure showed the ligand HL2 to exist as the zwitterionic (imine)N-H+···O(phenol) (ketoamine form) instead of usual (imine)N···H-O(phenol) (enolamine form) in the solid-state, and it displayed keto-enol tautomerism in solution as evidenced by 1H NMR studies. The structure for 1 or 2 confirmed coordination of the deprotonated Schiff base to the Rh(η4-cod)-fragment as a six-membered N^O-chelate around the Rh(I) with a close-to-square-planar geometry. There are two symmetry-independent molecules (with Rh1 and Rh2) in the asymmetric unit in 1, which gives a structure with Z′ = 2. The crystal packing analysis revealed both π-π and C-H···π contacts in HL2, while there were only two C-H···π contacts in 1 or 2. The reciprocal or pairwise C-H···π contacts (i.e., C-H to Rh-N^O metalloaromatic-ring) between a pair of each of the symmetry-independent molecules could be the reason for the two symmetry-independent molecules in 1.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28010172/s1, Figure S1. EI-mass spectra for complexes [Rh(η4-cod)(L1)] (1) (a) and [Rh(η4-cod)(L2)] (2) (b). Figure S2. 1H NMR spectrum for compound 1 in CDCl3 at 20 °C. EI-MS for 1 and 2. Figure S3. 1H NMR spectra for HL1 in DMSO-d6 (a) and for HL2 in CD3OD (b) and DMSO-d6 (c) at 20 °C. Figure S4. Sections of the packing diagram in HL2 along (a) a, (b) b and (c) presentation of the π-π and a C-H···π contact. Figure S5. Section of the packing diagram in 1 along a. Figure S6. Sections of the packing diagram in 2 along a (a) and b (b). Figure S7. Optimized structures for compounds 1 (a) and 2 (b) at B3LYO/SDD. Figure S8. The frontier HOMO-1, HOMO and LUMO orbitals for compound 1 calculated at B3LYP/SDD with PCM in chloroform. Figure S9. Simulated spectra for 2 with different combinations of the functionals and the basis sets (with PCM in chloroform). Gaussian band shape with exponential half-width s = 0.16 eV. Experimental spectrum for 2 (0.08 mM) in chloroform. Figure S10. Differential scanning calorimetry (DSC) curves for HL2. Table S1. Distance and angle details for the pairwise C-H···metallochelate-π contacts in 1. Table S2. Distance and angle details for C-H···π contacts in 2. Table S3. List of excited states, excitation energy (eV), wavelength (nm), oscillator strength (f) and MO contributions for compound 1 at B3LYP/SDD with PCM in chloroform. Table S4. List of excited states, excitation energy (eV), wavelength (nm), oscillator strength (f) and MO contributions for compound 2 at B3LYP/SDD with PCM in chloroform.

Author Contributions

Conceptualization, M.E. and C.J.; Methodology, M.E. and C.J.; Validation, M.E. and C.J.; Formal analysis, M.E., A.K.R., I.H. and D.W.; Investigation, M.E., A.K.R., D.W. and I.H.; Resources, M.E. and C.J.; Data Curation, M.E., A.K.R., I.H. and D.W.; Writing—Original Draft, M.E.; Writing—Review & Editing, M.E. and C.J.; Visualization, M.E., D.W. and C.J.; Supervision, M.E.; Project administration, M.E. and C.J.; Funding acquisition, M.E. and C.J. All authors have read and agreed to the published version of the manuscript.

Funding

The research was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under grant 440366605 (diffractometer).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding authors.

Acknowledgments

The authors acknowledge the financial support from the Alexander von Humboldt Foundation (AvH), Bonn, Germany under the Research Group Linkage Program. For computational resources, we thank Professor ABP Lever, Department of Chemistry, York University, Toronto, and the Digitial Research Alliance of Canada.

Conflicts of Interest

The authors declare that they have no known competing financial interest or personal relationships that could have appeared to influence the work reported in this paper.

Sample Availability

Not available.

References

  1. Cozens, R.J.; Murray, K.S.; West, B.O. Rhodium(I) and iridium(I) carbonyl and olefin derivatives of salicylaldimine schiff-bases. J. Organomet. Chem. 1971, 27, 399–407. [Google Scholar] [CrossRef]
  2. Platzer, N.; Goasdoue, N.; Bonnaire, R. Synthese et etude par resonance magnetique nucleaire de complexes olefiniques de l’iridium et du rhodium avec quelques bases de schiff derivees de l’aldehyde salicylique. J. Organomet. Chem. 1978, 160, 455–466. [Google Scholar] [CrossRef]
  3. Bonnaire, R.; Potvin, C.; Manoli, J.M. Crystal and molecular structures of (N-o-tolyl salicylideneiminato)(1,5-Cyclooctadiene)iridium(I) and of a novel binuclear (1,5-cyclooctadiene)rhodium(I) with bridging N,N′-(1,2-phenylene)bis(salicylideneiminato) ligand. Inorg. Chim. Acta 1980, 45, L255–L256. [Google Scholar] [CrossRef]
  4. Bonnaire, R.; Manoli, J.M.; Potvin, C.; Platzer, N.; Goasdoue, N.; Davoust, D. Crystal structure and solution dynamics of an unusual complex of rhodium(I) with the bridging Schiff base ligand µ-[N,N′-(o-phenylene)bis(salicylaldiminato)]-bis(η-1,5-cyclooctadiene)dirhodium(I). Inorg. Chem. 1982, 21, 2032–2037. [Google Scholar] [CrossRef]
  5. Matsinha, L.C.; Mapolie, S.F.; Smith, G.S. Recoverable and recyclable water-soluble sulphonated salicylaldimine Rh(I) complexes for 1-octene hydroformylation in aqueous biphasic media. Dalton Trans. 2015, 44, 1240–1248. [Google Scholar] [CrossRef] [Green Version]
  6. Williams, C.; Ferreira, M.; Monflier, E.; Mapolie, S.F.; Smith, G.S. Synthesis and hydroformylation evaluation of Fréchet-type organometallic dendrons with N,O-salicylaldimine Rh(I) complexes at the focal point. Dalton Trans. 2018, 47, 9418–9429. [Google Scholar] [CrossRef] [PubMed]
  7. Sekoto, P.N.; Magengenene, T.M.; Matsinha, L.C.; Tia, R.; Darkwa, J.; Makhubela, B.C.E. Catalytic isomerization–hydroformylation of olefins by rhodium salicylaldimine pre-catalysts. New J. Chem. 2020, 44, 8751–8762. [Google Scholar] [CrossRef]
  8. Siangwata, S.; Chulu, S.; Oliver, C.L.; Smith, G.S. Rhodium-catalysed hydroformylation of 1-octene using aryl and ferrocenyl Schiff base-derived ligands. Appl. Organomet. Chem. 2017, 31, e3593. [Google Scholar] [CrossRef]
  9. Gregory, S.; Laxman, R.K.; Fronczek, F.R.; Maverick, A.W.; Watkins, S.F. μ2-m-Xylylenebis(salicylaldiminato)-bis-(η4-1,5-cyclooctadiene)dirhodium(I)dichloromethane solvate. Acta Crystallogr. Sect. E Struct. Rep. Online 2012, 68, m1316–m1317. [Google Scholar] [CrossRef]
  10. Wu, X.; Zhang, P.; Yang, Z.; Zhang, S.; Liu, H.; Chi, W.; Li, X.; Dong, Y.; Qiu, N.; Yan, L. Polymerization of phenylacetylenes by binuclear rhodium catalysts with different para-binucleating phenoxyiminato linkages. Polym. Chem. 2019, 10, 4163–4172. [Google Scholar] [CrossRef]
  11. Brunner, H.; Fisch, H. Asymmetrische Katalysen XXXVI. Neue mehrzähnige Liganden mit dem (S)-(α)-(2-Pyridyl)ethylrest; Rh-Komplexe und enantioselektive Hydrosilylierungen. J. Organomet. Chem. 1987, 335, 1–14. [Google Scholar] [CrossRef]
  12. Brunner, H.; Riepl, G. Asymmetrische Hydrosilylierung von Acetophenon rnit Rhodium-Komplexen optisch aktiver Schiff-basen. Chem. Ber. 1982, 94, 369–370. [Google Scholar] [CrossRef]
  13. Brunner, H.; Reiter, B.; Riepl, G. Asymmetrische katalysen, enantioselektive hydrosilylierung prochiraler ketone mit Rh- und Pt-komplexen optisch aktiver N-chelatliganden. Chem. Ber. 1984, 117, 1330–1354. [Google Scholar] [CrossRef]
  14. Wright, M.E.; Svejda, S.A.; Arif, A.M. Synthesis of optically active Schiff base ligands from chiral 6-alkoxy-2-pyridinecarboxaldehydes and their application in rhodium catalyzed hydrosilations. Inorg. Chim. Acta 1990, 175, 13–15. [Google Scholar] [CrossRef]
  15. Zassinovich, G.; Grisoni, F. Enantioselective transfer hydrogenation of ketones catalyzed by Rhodium(I) complexes of chiral Schiff bases. J. Organomet. Chem. 1983, 247, c24–c26. [Google Scholar] [CrossRef]
  16. Jones, M.D.; Mahon, M.F. Synthesis of Rh(I) diamine complexes and their exploitation for asymmetric hydrogen transfer processes. J. Organomet. Chem. 2008, 693, 2377–2382. [Google Scholar] [CrossRef]
  17. Enamullah, M.; Uddin, A.; Chamayou, A.C.; Janiak, C. Syntheses, spectroscopy and crystal structures of (R)-N-(1-aryl-ethyl)salicylaldimines and Rh{(R)-N-(1-aryl-ethyl)salicylaldiminato}(h4-cod) complexes. Z. Naturforsch. B 2007, 62, 807–817. [Google Scholar] [CrossRef]
  18. Enamullah, M.; Royhan Uddin, A.K.M.; Hogarth, G.; Janiak, C. Synthesis, spectroscopy, catalysis and crystal structure of [Rh(η4-cod){(R)-N-(Ar)ethyl-2-oxo-1-naphthaldiminato-κ2N,O}] (Ar = C6H5, 3-/4-MeOC6H4, and 4-BrC6H4). Inorg. Chim. Acta 2012, 387, 173–180. [Google Scholar] [CrossRef]
  19. Enamullah, M.; Islam, M.A.; Janiak, C. Rh{(η4-cod) or (PPh3)2}-Schiff base complexes with a Z′ = 2 structure: Syntheses, spectroscopy, thermalanalyses and DFT/TDDFT. J. Mol. Struct. 2016, 1122, 331–340. [Google Scholar] [CrossRef]
  20. Janiak, C.; Chamayou, A.-C.; Royhan Uddin, A.K.M.; Uddin, M.; Hagen, K.S.; Enamullah, M. Polymorphs, enantiomorphs, chirality and helicity in [Rh{N,O}(η4-cod)] complexes with {N,O} = salicylaldiminato Schiff base or aminocarboxylato ligands. Dalton Trans. 2009, 19, 3698–3709. [Google Scholar] [CrossRef] [PubMed]
  21. Enamullah, M. Synthesis, spectroscopy, and catalysis of (η4-cod)Rh(I)-complexes with (R or S)-2-(salicylaldimine)-2-phenylethanol or (rac)-2-(salicylaldimine)-1-phenylethanol. J. Coord. Chem. 2012, 65, 911–922. [Google Scholar] [CrossRef]
  22. Enamullah, M.; Sharmin, A.; Hasegawa, M.; Hoshi, T.; Chamayou, A.-C.; Janiak, C. Syntheses, spectroscopic studies and crystal structures of chiral [Rh(aminocarboxylato)(η4-cod)] and chiral [Rh(amino alcohol)(η4-cod)](acetate) complexes with an example of a spontaneous resolution of a racemic mixture into Homo-Chiral Helix-Enantiomers. Eur. J. Inorg. Chem. 2006, 2006, 2146–2154. [Google Scholar] [CrossRef]
  23. Enamullah, M.; Islam, M.K.; Halim, M.A.; Janiak, C. Syntheses, spectroscopy, X-ray and DFT/TDDFT investigations of Rh(4-cod)-enantiopure aminocarboxylate complexes. J. Mol. Struct. 2015, 1099, 154–162. [Google Scholar] [CrossRef]
  24. Enamullah, M.; Royhan Uddin, A.K.M.; Hogarth, G. Synthesis, spectroscopy, and X-ray structures of 3-{(R)-(Ar)-ethylimino}-1,3-dihydro-indol-2 one (Ar = C6H5, MeOC6H4, BrC6H4, 1-naphthyl), and [Rh(η4-cod){3-((R)-(Ar)-ethylimino)-3H-indol-2-olato-2N,O}]. J. Coord. Chem. 2012, 65, 4263–4276. [Google Scholar] [CrossRef]
  25. Jorge, F.E.; Autschbach, J.; Ziegler, T. On the Origin of the Optical Activity in the d−d Transition Region of Tris-Bidentate Co (III) and Rh (III) Complexes. Inorg. Chem. 2003, 42, 8902–8910. [Google Scholar] [CrossRef] [PubMed]
  26. Flamigni, L.; Ventura, B.; Barigelletti, F.; Baranoff, E.; Collin, J.-P.; Sauvage, J.-P. Luminescent Iridium(III)-Terpyridine Complexes—Interplay of Ligand Centred and Charge Transfer States. Eur. J. Inorg. Chem. 2005, 2005, 1312–1318. [Google Scholar] [CrossRef]
  27. Draskovic, B.M.; Bogdanovic, G.A.; Neelakantan, M.A.; Chamayou, A.C.; Thalamuthu, S.; Avadhut, Y.S.; Schmedt auf der Günne, J.; Banerjee, S.; Janiak, C. N-o-Vanillylidene-l-histidine: Experimental Charge Density Analysis of a Double Zwitterionic Amino Acid Schiff-Base Compound. Cryst. Growth Des. 2010, 10, 1665–1676. [Google Scholar] [CrossRef]
  28. Nichol, G.S.; Clegg, W. Further thoughts on crystal structures with Z′ > 1: Analysis of single-crystal structures determined using X-ray synchrotron and neutron radiation in the Cambridge Structural Database. Cryst. Eng. Comm. 2007, 9, 959–960. [Google Scholar] [CrossRef]
  29. Steed, J.W. Should solid-state molecular packing have to obey the rules of crystallographic symmetry? Cryst. Eng. Comm. 2003, 5, 169–179. [Google Scholar] [CrossRef]
  30. Gavezotti, A. Structure and energy in organic crystals with two molecules in the asymmetric unit: Causality or chance? Cryst. Eng. Comm. 2008, 10, 389–398. [Google Scholar] [CrossRef]
  31. Desiraju, G.R. On the presence of multiple molecules in the crystal asymmetric unit (Z′ > 1). Cryst. Eng. Comm. 2007, 9, 91–92. [Google Scholar] [CrossRef]
  32. Ruiz, J.; Rodríguez, V.; Cutillas, N.; Hoffmann, A.; Chamayou, A.-C.; Kazmierczak, K.; Janiak, C. Structure—Solid-state CPMAS 13 C NMR correlation in palladacycle solvates (pseudo-polymorphs) with a transformation from Z′ = 1 to Z′ = 2. Cryst. Eng. Comm. 2008, 10, 1928–1938. [Google Scholar] [CrossRef]
  33. Vasylyeva, V.; Kedziorski, T.; Metzler-Nolte, N.; Schauerte, C.; Merz, K. Polymorphism of Pyridine-N-oxide and Its Deuterated Analogues. Cryst. Growth Des. 2010, 10, 4224–4226. [Google Scholar] [CrossRef]
  34. Roy, S.; Banerjee, R.; Nangia, A.; Kruger, G.J. Conformational, Concomitant Polymorphs of 4,4-Diphenyl-2,5-cyclohexadienone: Conformation and Lattice Energy Compensation in the Kinetic and Thermodynamic Forms. Chem. Eur. J. 2006, 12, 3777–3788. [Google Scholar] [CrossRef] [PubMed]
  35. Hernandez, J.O.; Portilla, J.; Cobo, J.; Glidewell, C. Two different products from the reaction of 1-aryl-5-chloro-3-methyl-1H-pyrazole-4-carbaldehyde with cyclohexylamine when the aryl substituent is phenyl or pyridin-2-yl: Hydrogen-bonded sheets versus dimers. Acta Cryst. 2015, C71, 363–368. [Google Scholar] [CrossRef] [PubMed]
  36. Sarojini, B.K.; Yathirajan, H.S.; Hosten, E.C.; Betz, R.; Glidewell, C. Ethyl (4-benzyl-oxyphen-yl)-6-methyl-2-sulfanyl-idene-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate and a redetermination of ethyl (4RS)-4-(4-meth-oxy-phen-yl)-6-methyl-2-sulfanyl-idene-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate, as its 0.105-hydrate, both at 200 K: Subtly different hydrogen-bonded ribbons. Acta Cryst. 2015, C71, 59–64. [Google Scholar] [CrossRef]
  37. Althoff, G.; Ruiz, J.; Rodríguez, V.; López, G.; Pérez, J.; Janiak, C. Can a single C-H⋯F-C hydrogen bond make a difference? Assessing the H⋯F bond strength from 2-D 1H-19F CP/MAS NMR. Cryst. Eng. Comm. 2006, 8, 662–665. [Google Scholar] [CrossRef]
  38. Hao, X.; Parkin, S.; Brock, C.P. The unusual phases of anhydrous and hydrated pinacol. Acta Crystallogr. Sect. B Struct. Sci. 2005, B61, 689–699. [Google Scholar] [CrossRef] [PubMed]
  39. Babu, N.J.; Nangia, A. High Z′ polymorphs have shorter C-H⋯O interactions and O-H⋯O hydrogen bonds. Cryst. Eng. Comm. 2007, 9, 980–983. [Google Scholar] [CrossRef]
  40. Chamayou, A.-C.; Biswas, C.; Ghosh, A.; Janiak, C. (Acetato-κO)aqua(1H-imidazole-κN3)(picolinato-κ2N,O)copper(II) 0.87-hydrate: A Z > 1 structure. Acta Cryst. 2009, C65, m311–m313. [Google Scholar] [CrossRef]
  41. Makhloufi, G.; Schütte, K.; Janiak, C. The crystal structure of N-(1-(dimethyl-l4-azanylidene)ethyl)propan-2-amine, a Z′ > 1 structure, C8H18N2. Z. Kristallogr. NCS 2014, 229, 429–430. [Google Scholar] [CrossRef]
  42. Kirchner, M.T.; Bläser, D.; Boese, R.; Desiraju, G.R. Additive induced polymorphism. The pentafluorophenol–pentafluoroaniline system. Cryst. Eng. Comm. 2009, 11, 229–231. [Google Scholar] [CrossRef]
  43. Masui, H. Metalloaromaticity. Coord. Chem. Rev. 2001, 219–221, 957–992. [Google Scholar] [CrossRef]
  44. Castineiras, A.; Sicilia-Zafra, A.G.; González-Pérez, J.M.; Choquesillo-Lazarte, D.; Niclós-Gutiérrez, J. Intramolecular “Aryl—Metal Chelate Ring” π, π-Interactions as Structural Evidence for Metalloaromaticity in (Aromatic α,α′-Diimine)—Copper (II) Chelates: Molecular and Crystal Structure of Aqua (1, 10-phenanthroline)(2-benzylmalonato) copper (II) Three-hydrate. Inorg. Chem. 2002, 41, 6956–6958. [Google Scholar] [CrossRef] [PubMed]
  45. Craven, E.; Zhang, C.; Janiak, C.; Rheinwald, G.; Lang, H. Synthesis, Structure and Solution Chemistry of (5,5′-Dimethyl-2,2′-bipyridine)(IDA)copper(II) and Structural Comparison With Aqua(IDA) (1,10-phenanthroline)copper(II) (IDA = iminodiacetato). Z. Anorg. Allg. Chem. 2003, 629, 2282–2290. [Google Scholar] [CrossRef]
  46. Monfared, H.H.; Kalantari, Z.; Kamyabi, M.-A.; Janiak, C. Synthesis, Structural Characterization and Electrochemical Studies of a Nicotinamide-bridged Dinuclear Copper Complex derived from a Tridentate Hydrazone Schiff Base Ligand. Z. Anorg. Allg. Chem. 2007, 633, 1945–1948. [Google Scholar] [CrossRef]
  47. Zhang, W.; Tang, X.; Ma, H.; Sun, W.-H.; Janiak, C. {2-[1-(2,6-diisopropylphenylimino)ethyl]pyridyl}palladium dibromide polymorphs originating from different Br··· and C-H···Br contacts. Eur. J. Inorg. Chem. 2008, 2008, 2830–2836. [Google Scholar] [CrossRef]
  48. Monfared, H.H.; Vahedpour, M.; Yeganeh, M.M.; Ghorbanloo, M.; Mayer, P.; Janiak, C. Concentration dependent tautomerism in green [Cu(HL1)(L2)] and brown [Cu(L1)(HL2)] with H2L1 = (E)-N′-(2-hydroxy-3-methoxybenzylidene)benzoylhydrazone and HL2 = pyridine-4-carboxylic (isonicotinic) acid. Dalton Trans. 2011, 40, 1286–1294. [Google Scholar] [CrossRef] [Green Version]
  49. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.; et al. Gaussian 16; Revision A.03; Gaussian, Inc.: Wallingford, CT, USA, 2016. [Google Scholar]
  50. Andrae, D.; Häußermann, U.; Dolg, M.; Stoll, H.; Preuß, H. Energy-adjusted ab initio pseudopotentials for the second and third row transition elements. Theor. Chim. Acta 1990, 77, 123–141. [Google Scholar] [CrossRef]
  51. Fuentes, J.A.; Wawrzyniak, P.; Roff, G.J.; Bühl, M.; Clarke, M.L. On the rate-determining step and the ligand electronic effects in rhodium catalysed hydrogenation of enamines and the hydroaminomethylation of alkenes. Catal. Sci. Technol. 2011, 1, 431–436. [Google Scholar] [CrossRef]
  52. George, M.W.; Hall, M.B.; Jina, O.S.; Portius, P.; Sun, X.-Z.; Towrie, M.; Wu, H.; Yang, X.; Zarić, S.D. Understanding the factors affecting the activation of alkane by Cp’Rh(CO)2 (Cp’ = Cp or Cp *). Proc. Natl. Acad. Sci. USA 2010, 107, 20178–20183. [Google Scholar] [CrossRef] [Green Version]
  53. Bruhn, T.; Schaumlöffel, A.; Hemberger, Y.; Bringmann, G. SpecDis: Quantifying the Comparison of Calculated and Experimental Electronic Circular Dichroism Spectra. Chirality 2013, 25, 243–249. [Google Scholar] [CrossRef] [PubMed]
  54. Bruhn, T.; Schaumlöffel, A.; Hemberger, Y.; Pescitelli, G. SpecDis, version 1.71; Berlin, Germany. 2017. Available online: https://specdis-software.jimdo.com (accessed on 15 November 2022).
  55. Rigaku Oxford Diffraction Ltd. CrysAlisPro; Release 1.171.40.103a; Rigaku Oxford Diffraction Ltd.: Yarnton, UK, 2021. [Google Scholar]
  56. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Cryst. Struct. Commun. 2015, C71, 3–8. [Google Scholar] [CrossRef] [Green Version]
  57. Sheldrick, G.M. A short history of SHELX. Acta Crystallogr. A Found. Crystallogr. 2008, 64, 112–122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  59. Brandenburg, K. Diamond (Version 4.6). Crystal and Molecular Structure Visualization, Crystal Impact GbR; Copyright 1997–2022; Brandenburg & H. Putz Gbr: Bonn, Germany, 2017. [Google Scholar]
  60. Spek, A.L. PLATON—A Multipurpose Crystallographic Tool; Utrecht University: Utrecht, The Netherlands, 2008. [Google Scholar]
  61. Farrugia, L.J. Windows Implementation; Version 270519; University of Glasgow: Scotland, UK, 2019. [Google Scholar]
  62. Spek, A.L. Structure validation in chemical crystallography. Acta Crystallogr. D Biol. Crystallogr. 2009, D65, 148–155. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Scheme 1. Formula of HL1, HL2 (with NMR atom numbering), 1 and 2.
Scheme 1. Formula of HL1, HL2 (with NMR atom numbering), 1 and 2.
Molecules 28 00172 sch001
Scheme 2. Synthetic route to the formation of the Schiff bases HL1 and HL2 as well as Rh(η4-cod)-Schiff bases complexes 1 and 2.
Scheme 2. Synthetic route to the formation of the Schiff bases HL1 and HL2 as well as Rh(η4-cod)-Schiff bases complexes 1 and 2.
Molecules 28 00172 sch002
Figure 1. 1H NMR spectra of the Schiff base (a) HL2 with hydrogen atoms numbered and (b) compound 2 in CDCl3 at 20 °C.
Figure 1. 1H NMR spectra of the Schiff base (a) HL2 with hydrogen atoms numbered and (b) compound 2 in CDCl3 at 20 °C.
Molecules 28 00172 g001
Figure 2. UV-Vis spectra for HL1 (0.10 mM), 1 (0.20 mM) and 2 (0.08 mM) in chloroform at 25 °C.
Figure 2. UV-Vis spectra for HL1 (0.10 mM), 1 (0.20 mM) and 2 (0.08 mM) in chloroform at 25 °C.
Molecules 28 00172 g002
Figure 3. Experimental and simulated spectra for compounds 1 (0.20 mM) and 2 (0.08 mM) in chloroform (spectra simulated at B3LYP/SDD with PCM in chloroform). Gaussian band shape with exponential half-width s = 0.16 eV.
Figure 3. Experimental and simulated spectra for compounds 1 (0.20 mM) and 2 (0.08 mM) in chloroform (spectra simulated at B3LYP/SDD with PCM in chloroform). Gaussian band shape with exponential half-width s = 0.16 eV.
Molecules 28 00172 g003
Figure 4. The frontier HOMO-1, HOMO and LUMO orbitals for compound 2 calculated at B3LYP/SDD with PCM in chloroform.
Figure 4. The frontier HOMO-1, HOMO and LUMO orbitals for compound 2 calculated at B3LYP/SDD with PCM in chloroform.
Molecules 28 00172 g004
Figure 5. Molecular structures for compounds HL2 (a), 1 (b) and 2 (c) (50% thermal ellipsoids). There is a disorder in the cod ring in the Rh2 molecule in 1.
Figure 5. Molecular structures for compounds HL2 (a), 1 (b) and 2 (c) (50% thermal ellipsoids). There is a disorder in the cod ring in the Rh2 molecule in 1.
Molecules 28 00172 g005aMolecules 28 00172 g005b
Figure 6. The reciprocal or pairwise C-H···metallochelate-π contacts between a pair of each of the symmetry-independent molecules in 1 with Rh1 (a) and Rh2 (b) (distance and angle details are given in Table S1). For clarity, the H atoms were omitted except for those of the C-H···π contact. Symmetry transformation i = –x, 1–y, 1–z; ii = 2–x, 1–y, 2–z.
Figure 6. The reciprocal or pairwise C-H···metallochelate-π contacts between a pair of each of the symmetry-independent molecules in 1 with Rh1 (a) and Rh2 (b) (distance and angle details are given in Table S1). For clarity, the H atoms were omitted except for those of the C-H···π contact. Symmetry transformation i = –x, 1–y, 1–z; ii = 2–x, 1–y, 2–z.
Molecules 28 00172 g006
Scheme 3. Keto-enol tautomerism of HL2 in solution.
Scheme 3. Keto-enol tautomerism of HL2 in solution.
Molecules 28 00172 sch003
Figure 7. Differential scanning calorimetry (DSC) curves for compounds 1 and 2.
Figure 7. Differential scanning calorimetry (DSC) curves for compounds 1 and 2.
Molecules 28 00172 g007
Table 1. 1H NMR (400 MHz) data for the Schiff bases and complexes at 20 °C.
Table 1. 1H NMR (400 MHz) data for the Schiff bases and complexes at 20 °C.
EntitySolventsAssignments
CH3CH2CH2codexo/
CH2codendo
CHcod CHNOH/NHH-Ar
HL1CDCl31.28 (t, JHH = 7.6 Hz)2.84 (q, JHH = 7.6 Hz) 8.62 (s)13.47 (br)6.99 (t, JHH = 7.6 Hz, 1H, H4), 7.08 (d, JHH = 8.0 Hz, 1H, H2), 7.13 (dd, JHH = 6.4, 1.6 Hz, 1H, H12), 7.27–7.33 (m, 3H, H10,11,13), 7.40–7.46 (m, 2H, H3,5)
DMSO-d61.17 (t, JHH = 7.6 Hz)2.73 (q, JHH = 7.6 Hz) 8.90 (s)13.31 (br)6.97–7.02 (m, 2H, H2,4), 7.25–7.28 (m, 1H, H12), 7.29–7.33 (m, 3H, H10,11,13), 7.44 (t, JHH = 7.0 Hz, 1H, H3), 7.68 (d, JHH = 7.6 Hz, 1H, H5)
HL2CDCl3 1.34 (t, JHH = 7.6 Hz)2.90 (q, JHH = 7.6 Hz) 9.34 (s)15.63 (br) 7.17 (d, JHH = 9.2 Hz, 1H, H14), 7.30 (d, JHH = 9.6 Hz, 1H, H17), 7.35–7.39 (m, 4H, H2,6,15,16), 7.55 (t, JHH = 8.0 Hz, 1H, H7), 7.74 (d, JHH = 8.0 Hz, 1H, H8), 7.84 (d, JHH = 9.2 Hz, 1H, H5), 8.13 (d, JHH = 8.4 Hz, 1H, H3)
CD3OD1.33 (m)2.88 (m) 9.46, 9.51 (18.0 Hz) 6.94 (t, JHH = 8.8 Hz, 1H, H16), 7.24–7.41 (m, 4H, H2,14,15,17), 7.51–7.56 (m, 1H, H6), 7.64–7.72 (m, 2H, H7,8), 7.85 (t, JHH = 10.0 Hz, 1H, H5), 8.24–8.29 (m, 1H, H3)
DMSO-d6 1.24 (t, JHH = 7.6 Hz)2.81 (q, JHH = 7.6 Hz) 9.65, 9.66 (5.0 Hz)16.06, 16.07 (5.0 Hz)7.04 (d, JHH = 9.2 Hz, 1H, H14), 7.27 (t, JHH = 7.2 Hz, 1H, H16), 7.35–7.40 (m, 3H, H2,15,17), 7.55 (t, JHH = 7.6 Hz, 1H, H6), 7.80 (t, JHH = 7.6 Hz, 2H, H7,8), 7.95 (d, JHH = 9.2 Hz, 1H, H5), 8.51 (d, JHH = 8.4 Hz, 1H, H3)
1CDCl3 1.33 (t, JHH = 7.6 Hz)2.93 (q, JHH = 6.8 Hz)1.77–1.79/2.52–2.54 (m)4.27 (s)8.77 (s) 7.05–7.07 (m, 1H, H-Ar), 7.21–7.27 (m, 1H, H-Ar), 7.38–7.49 (m, 4H, H-Ar), 7.61–7.65 (m, 2H, H-Ar)
2CDCl3 1.35 (t, JHH = 7.6 Hz)2.92 (q, JHH = 6.8 Hz)1.77–1.79/2.52–2.54 (m)4.26 (s)9.36 (s) 7.37–7.43 (m, 4H, H-Ar), 7.55–7.68 (m, 2H, H-Ar), 7.77 (d, JHH = 7.6 Hz, 1H, H-Ar), 7.93–7.99 (m, 2H, H-Ar), 8.14 (d, JHH = 7.2, Hz, 1H, H-Ar)
s = singlet, d = doublet, t = triplet, dd = doublet of doublets, dt = doublet of triplets, m = multiplet.
Table 2. Selected excited state properties and assignments for 1 and 2, calculated at B3LYP/SDD with PCM in chloroform.
Table 2. Selected excited state properties and assignments for 1 and 2, calculated at B3LYP/SDD with PCM in chloroform.
Wavelength (nm) aExcited StatesOscillator StrengthElectronic Transition (MOs Contribution, %) bAssignments c
Compound 1
475 10.0022H→L (98)MM, ML
402 (399)20.0426H-1→L (71)MM, ML
361 40.0217H-3→L (42), H-2→L (54)MM, ML, LL
335 (ca. 310 sh)70.1432H-3→L (54), H-2→L (38)MM, ML, LL
291120.1853H-1→L + 1 (18), H-1→L + 2 (42)MM, ML, LL
246 290.2134H-2→L + 1 (12), H-1→L + 6 (32)MM, ML, LL
228 410.1113 H-4→L + 1 (12), H→L + 9 (11)ML, LL
212550.2316H-7→L + 1 (17), H-1→L + 11 (12) MM, LL
Compound 2
487 10.0030H→L (97)MM, ML
410 (417)20.0662H-1→L (76)MM, ML, LL
348 60.2166H-3→L (40), H-2→L (52)MM, ML, LL
311 (323)100.2079H-1→L+1 (53)MM, ML, LL
285 (275)170.0700H-1→L+3 (26), H→L+6 (22)MM, ML, LL
249 330.1012H-3→L+1 (19), H-3→L + 3 (28)MM, ML, LL
233 440.1513 H-4→L+1 (9), H-4→L + 3 (36)ML, LL
215650.2176H-4→L+5 (11), H-3→L + 11 (11)ML, LL
a Experimental values are in parentheses; b H/L = HOMO/LUMO and MOs = molecular orbitals; c MM = metal centered d–d transitions; ML = metal–ligand/ligand–metal charge transfer transitions, LL = intra-ligand charge transfer transitions.
Table 3. Selected bond lengths [Å] and angles [°] in the X-ray and optimized structures for HL2, 1 and 2.
Table 3. Selected bond lengths [Å] and angles [°] in the X-ray and optimized structures for HL2, 1 and 2.
Compound HL2Compound 1Compound 2
X-rayX-ray (with Rh1)Opt. Str.X-ray (with Rh2) X-rayOpt. Str.
C1-O1
C11-N1
C12-N1
N1-H1
C11-H11
C1-C10
C10-C11

O1-C1-C10
C11-N1-C12
C10-C11-N1
C11-N1-H1
C12-N1-H1
1.270 (2)
1.324 (2)
1.413 (1)
0.95 (2)
0.950 (0)
1.450 (2)
1.387 (2)

122.3 (1)
126.3 (1)
124.0 (1)
113.0 (1)
121.0 (1)
Rh1–O1
Rh1–N1
Rh1–C16
Rh1–C17
Rh1–C20
Rh1–C21
C1-O1
C7-N1
C8-N1
C16-C17
C20-C21

O1-Rh-N1
O1-Rh-C16
O1-Rh-C17
O1-Rh-C20
O1-Rh-C21
N1-Rh-C16
N1-Rh-C17
N1-Rh-C20
N1-Rh-C21
2.037 (2)
2.080 (2)
2.113 (2)
2.118 (2)
2.130 (2)
2.139 (2)
1.300 (3)
1.298 (3)
1.450 (3)
1.404 (3)
1.391 (3)

90.35 (7)
159.16 (8)
160.29 (8)
84.98 (8)
87.92 (8)
94.21 (8)
96.48 (8)
157.90 (8)
163.56 (8)
2.044
2.099
2.155
2.175
2.174
2.195
1.328
1.327
1.456
1.425
1.416

89.75
157.71
161.19
84.71
87.37
95.98
98.23
157.07
164.21
Rh2–O2
Rh2–N2
Rh2–C39
Rh2–C40
Rh2–C43
Rh2–C44
C24-O2
C30-N2
C31-N2
C39-C40
C43-C44

O2-Rh-N2
O2-Rh-C39
O2-Rh-C40
O2-Rh-C43
O2-Rh-C44
N2-Rh-C39
N2-Rh-C40
N2-Rh-C43
N2-Rh-C44
2.026 (2)
2.084 (2)
2.124 (2)
2.119 (2)
2.137 (2)
2.129 (2)
1.301 (3)
1.295 (3)
1.450 (3)
1.402 (3)
1.386 (4)

90.44 (7)
162.34 (8)
156.99 (8)
85.59 (8)
86.34 (8)
95.04 (8)
96.61 (8)
163.79 (8)
157.51 (8)
Rh1–O1
R1h–N1
Rh1–C20
Rh1–C21
Rh1–C24
Rh1–C25
C1-O1
C11-N1
C12-N1
C20-C21
C24-C25

O1-Rh-N1
O1-Rh-C20
O1-Rh-C21
O1-Rh-C24
O1-Rh-C25
N1-Rh-C20
N1-Rh-C21
N1-Rh-C24
N1-Rh-C25
2.025 (2)
2.076 (3)
2.112 (3)
2.133 (4)
2.126 (3)
2.148 (4)
1.294 (4)
1.307 (5)
1.456 (5)
1.401 (5)
1.388 (5)

88.70 (1)
153.10 (1)
166.40 (1)
87.40 (1)
86.50 (1)
97.60 (1)
96.70 (1)
152.00 (1)
168.70 (1)
2.048
2.087
2.160
2.181
2.181
2.205
1.329
1.332
1.461
1.423
1.415

88.35
157.72
162.05
86.19
88.65
96.48
98.25
156.56
164.91
Opt. Str. = Optimized structure at B3LYP/SDD.
Table 4. Phase transformation and thermal stability for the compounds.
Table 4. Phase transformation and thermal stability for the compounds.
CompoundsPeaks Temperature/°C (Heating Curve)ΔH (kJ mol–1)
HL292 (1st cycle)−19.93
89 (2nd cycle)−15.60
1185 (1st cycle)−19.77
2221 (1st cycle)−37.57
Table 5. Crystal data and structure refinement for HL2, 1 and 2.
Table 5. Crystal data and structure refinement for HL2, 1 and 2.
HL212
FormulaC19H17NOC23H26NORhC27H28NORh
Mr275.33435.36485.41
Cryst. size, mm30.17 × 0.20 × 0.810.06 × 0.07 × 0.140.04 × 0.03 × 0.12
Crystal systemmonoclinicmonoclinic monoclinic
Temp. (K)100100100
Space groupI2/aP21/nP21/c
a, Å14.4394 (2)10.6023 (1)10.5105 (2)
b, Å5.92690 (10)18.6289 (1)7.44870 (10)
c, Å33.3937 (5)19.2399 (1)27.3231 (5)
β, deg102.4790 (10)98.696 (1)94.400 (2)
V, Å32790.35 (7)3756.37 (5)2132.81 (6)
Z884
Dcalcd, g cm−31.3111.5401.512
μ, mm−1
θ range (°)
0.630
2.7–67.1
7.425
3.2–67.1
6.606
3.2–78.4
F(000)116817921000
Trans. (max/min)0.979/0.9790.662/0.6420.930/0.930
hkl range±17; ±7; ±3912; 22; 22±12; ±8; ±32
Refl. measured239765175924582
Refl. unique249267053812
Rint0.04360.03220.0382
Param. refined/restraints195/0481/0272/0
GoF (F2) a1.0481.0481.249
R1/wR2 [I>2σ (I)] b0.0377/0.10030.0226/0.05700.0358/0.0764
R1/wR2 (all data) b0.0400/0.10220.0246/0.05790.0374/0.0770
Max./min. Δρ (e. Å−3) c 0.192/–0.2220.576/–0.6350.818/–0.875
CCDC number220115422011552201156
a Goodness-of-fit = [∑[w(Fo2 − Fc2)2]/(n − p)]1/2; b R1 = [∑(||Fo| − |Fc||)/∑|Fo|]; wR2 = [∑[w(Fo2 − Fc2)2]/∑[w(Fo2)2]]1/2; c Largest difference peak and hole.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Enamullah, M.; Haque, I.; Resma, A.K.; Woschko, D.; Janiak, C. Schiff Base in Ketoamine Form and Rh(η4-cod)-Schiff Base Complex with Z′ = 2 Structure from Pairwise C-H···Metallochelate-π Contacts. Molecules 2023, 28, 172. https://doi.org/10.3390/molecules28010172

AMA Style

Enamullah M, Haque I, Resma AK, Woschko D, Janiak C. Schiff Base in Ketoamine Form and Rh(η4-cod)-Schiff Base Complex with Z′ = 2 Structure from Pairwise C-H···Metallochelate-π Contacts. Molecules. 2023; 28(1):172. https://doi.org/10.3390/molecules28010172

Chicago/Turabian Style

Enamullah, Mohammed, Imdadul Haque, Amina Khan Resma, Dennis Woschko, and Christoph Janiak. 2023. "Schiff Base in Ketoamine Form and Rh(η4-cod)-Schiff Base Complex with Z′ = 2 Structure from Pairwise C-H···Metallochelate-π Contacts" Molecules 28, no. 1: 172. https://doi.org/10.3390/molecules28010172

APA Style

Enamullah, M., Haque, I., Resma, A. K., Woschko, D., & Janiak, C. (2023). Schiff Base in Ketoamine Form and Rh(η4-cod)-Schiff Base Complex with Z′ = 2 Structure from Pairwise C-H···Metallochelate-π Contacts. Molecules, 28(1), 172. https://doi.org/10.3390/molecules28010172

Article Metrics

Back to TopTop